Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma

Oncotarget. 2018 Nov 9;9(88):35870. doi: 10.18632/oncotarget.26359.

Authors

Jon Bjoern^{1

2}, Rikke Lyngaa^{3

1}, Rikke Andersen^{1

2}, Lisbet Rosenkrantz Hölmich⁴, Sine Reker Hadrup^{3

1}, Marco Donia^{1

2}, Inge Marie Svane^{1

2}

Affiliations

¹ Center for Cancer Immune Therapy, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
² Department of Oncology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
³ Section for Immunology and Vaccinology, Technical University of Denmark, Copenhagen, Denmark.
⁴ Department of Plastic Surgery, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.16003.].

Publication types

Published Erratum